Dr Persic is a Consultant Clinical Oncologist with special interest in breast cancer, gynaecological cancers, lymphomas and sarcomas.
Dr Persic works in Derby Burton hospitals and in the private sector offering treatment with chemotherapy and radiotherapy for patients with cancer. She is endeavours to deliver best possible care to patients including offering the most up-to-date treatments.Dr Persic is passionate about the research and is the Principal Investigator for breast and gynaecological clinical trials.
Clinical interests
- Breast
- Gynaecology
- Haematological
- Soft tissue
- Breast cancer
- Gynaecological oncology
- Ovarian cancer
- Cervix cancer
- Uterus cancer
- Soft tissues sarcoma
- Radiotherapy for lymphoma
Publications & affiliations
- Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial (July 2021)
- Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial (March 2020)
- Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials (Nov 2018)
- Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial (Oct 2018)
Professional memberships
- Member of the Royal College of Physicians (RCP)
- Fellow of the Royal College of Radiotherapy (RCR)